Integrity of a HPV11 infection cell model and identification of (-)-epigallocatechin-3-gallate as a potential HPV11 inhibitor

Oncotarget

Volumn 7, Issue 24, 2016, Pages 37092-37102

  Sun, Yang ^a   Li, Xinyu ^a   Song, Shasha ^a   Wang, Yongfang ^a   Gu, Heng ^a  

^a INSTITUTE OF DERMATOLOGY   (China)

Author keywords

Condyloma acuminatum; Early genes; HPV11; IFN pathway; Model

Indexed keywords

EPIGALLOCATECHIN GALLATE; MESSENGER RNA; PROTEIN E6; PROTEIN E7; RECOMBINANT ALPHA2A INTERFERON; ALPHA INTERFERON; CATECHIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11; E7 PROTEIN, HUMAN PAPILLOMAVIRUS 11; IFNA2 PROTEIN, HUMAN; ONCOPROTEIN; RECOMBINANT PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; E3 GENE; E7 GENE; GENE EXPRESSION; HUMAN PAPILLOMAVIRUS TYPE 11; PAPILLOMAVIRUS INFECTION; VIRUS GENE; VIRUS GENOME; ANALOGS AND DERIVATIVES; CELL CULTURE TECHNIQUE; CELL CYCLE; CELL SEPARATION; CONDYLOMA ACUMINATUM; DRUG EFFECTS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; KERATINOCYTE; METABOLISM; PROCEDURES; SIGNAL TRANSDUCTION; TRANSFORMED CELL LINE; VIROLOGY;

CATECHIN; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELL SEPARATION; CONDYLOMATA ACUMINATA; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 11; HUMANS; INTERFERON-ALPHA; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84978100687     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9249     Document Type: Article

References (22)

1. Bae JM. Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis. Epidemiology and health. 2015; 37:e2015005.
2. Lee LA, Huang CG, Tsao KC, Liao CT, Kang CJ, Chang KP, Huang SF, Chen IH, Fang TJ, Li HY, Yang SL, Lee LY, Hsueh C, et al. Increasing rates of lowrisk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2013; 57:331-337.
3. Bzhalava D, Guan P, Franceschi S, Dillner J and Clifford G. A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology. 2013; 445:224-231.
4. de Villiers EM, Fauquet C, Broker TR, Bernard HU and zur Hausen H. Classification of papillomaviruses. Virology. 2004; 324:17-27.
5. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clinical science. 2006; 110:525-541.
6. Brown DR, Bryan JT, Pratt L, Handy V, Fife KH and Stoler MH. Human Papillomavirus Type 11 E1 up angle E4 and L1 Proteins Colocalize in the Mouse Xenograft System at Multiple Time Points. Virology. 1995; 214:259-263.
7. Parkinson T, Howett MK, Welsh PA, Patrick SD, Neely EB, Flanagan N, Pollack VA, Pustilnik LR, Moyer J and Perros M. An inhibitor of the epidermal growth factor receptor function does not affect the ability of human papillomavirus 11 to form warts in the xenografted immunodeficient mouse model. Antiviral research. 2007; 74:43-50.
8. Wang Y, Li X, Song S and Wu J. Development of Basal-Like HaCaT Keratinocytes Containing the Genome of Human Papillomavirus (HPV) Type 11 for Screening of Anti-HPV Effects. Journal of biomolecular screening. 2014; 19:1154-1163.
9. Wang Y, Li X and Song S. Establishment of threedimensional culture model by HaCaT keratinocytes carrying HPV11 genome and expression of HPV 11 major capsid protein L1 in this model. Chinese Journal of AIDS & STD. 2010; 2:105-108.
10. Le Bon A and Tough DF. Links between innate and adaptive immunity via type I interferon. Current opinion in immunology. 2002; 14:432-436.
11. Kanodia S, Fahey LM and Kast WM. Mechanisms used by human papillomaviruses to escape the host immune response. Current cancer drug targets. 2007; 7:79-89.
12. Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE and Um SJ. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. Journal of Biological Chemistry. 2000; 275:6764-6769.
13. Ronco LV, Karpova AY, Vidal M and Howley PM. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes & development. 1998; 12:2061-2072.
14. Chow LT, Broker TR and Steinberg BM. The natural history of human papillomavirus infections of the mucosal epithelia. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 2010; 118:422-449.
15. Doorbar J. The papillomavirus life cycle. Journal of clinical virology. 2005; 32 Suppl 1:7-15.
16. Doorbar J. Model systems of human papillomavirus-associated disease. The Journal of pathology. 2016; 238:166-179.
17. Ruesch MN, Stubenrauch F and Laimins LA. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10. J Virol. 1998; 72:5016-5024.
18. Eckert RL, Crish JF, Efimova T, Dashti SR, Deucher A, Bone F, Adhikary G, Huang G, Gopalakrishnan R and Balasubramanian S. Regulation of involucrin gene expression. The Journal of investigative dermatology. 2004; 123:13-22.
19. Nestle FO, Di Meglio P, Qin JZ and NickoloffBJ. Skin immune sentinels in health and disease. Nature reviews Immunology. 2009; 9:679-691.
20. Miller LS and Modlin RL. Human keratinocyte Toll-like receptors promote distinct immune responses. The Journal of investigative dermatology. 2007; 127:262-263.
21. Abdul-Sater AA, Majoros A, Plumlee CR, Perry S, Gu AD, Lee C, Shresta S, Decker T and Schindler C. Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs. Journal of immunology. 2015; 195:210-216.
22. Schindler C, Levy DE and Decker T. JAK-STAT signaling: from interferons to cytokines. The Journal of biological chemistry. 2007; 282:20059-20063.